Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Health Network, Toronto
Washington University School of Medicine
Arbeitsgemeinschaft medikamentoese Tumortherapie
Taproot Health
Cedars-Sinai Medical Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center